YXG-158

N/A

Report date: 2023/07/20 18:00:18
NME

Base Information

Drug NameYXG-158
Drug Alias NameYXG-158
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor degradersSteroid 17-alpha-hydroxylase inhibitors
TargetsAndrogen ReceptorSteroid 17-alpha-hydroxylase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A